US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Moleculin Biotech

4.22

+0.04000.96%

Volume:18.77K

Turnover:78.69K

Market Cap:12.99M

PE:-0.05

High:4.26

Open:4.22

Low:4.07

Close:4.18

52wk High:91.25

52wk Low:3.13

Shares:3.08M

Float Shares:3.03M

Volume Ratio:0.30

T/O Rate:0.62%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-78.8608

EPS(LYR):-158.0236

ROE:-503.80%

ROA:-69.18%

PB:-0.48

PE(LYR):-0.03

Loading ...

Overview Company News Filings

Moleculin Biotech Inc. Held Special Stockholder Meeting

Moleculin Biotech nimmt an virtueller Corporate-Connect-Konferenz von Webull Financial teil

BUZZ-Moleculin Biotech rises as cancer drug shows no heart damage in trials

Moleculin Biotech Reports Annamycin Shows No Cardiotoxicity in 90 Clinical Trial Subjects

BRIEF-Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding On Track, Global Trial Expansion, And Multiple Externally/Iit Funded Clinical Programs

Moleculin Biotech Inc - First Miracle Trial Unblinding Expected Q1 2026; Global Trial NOW Spans Nine Countries

THOMSON REUTERS

Moleculin Biotech Inc - Primary Efficacy Data for Miracle Expected in 2028

THOMSON REUTERS

BRIEF-Moleculin Biotech Regains Nasdaq Listing Compliance

Moleculin Biotech Inc - Regains Nasdaq Listing Compliance - SEC Filing

THOMSON REUTERS

Moleculin Biotech Inc. Announces Date for Upcoming Special Stockholders Meeting

Moleculin Reports Positive Phase 1 Results for WP1066 in Pediatric Brain Tumors

Moleculin Biotech Inc - WP1066 Found Safe and Effective, Warranting Phase 2 Trial

THOMSON REUTERS

Moleculin Announces Positive Results From Phase 1 Clinical Trial Evaluating WP1066 for the Treatment of Pediatric Recurrent Malignant Brain Tumors

THOMSON REUTERS

Moleculin Biotech Is Maintained at Buy by HC Wainwright & Co.

Moleculin Biotech Raises $6.8 Million Through Warrant Exercises

Moleculin Biotech Nears First Unblinding in Pivotal Phase 3 AML Trial

Moleculin Announces Completion of Treatment for the 45 Patients in Pivotal “Miracle” Phase 3 Aml Trial on Pace for Q1 2026

THOMSON REUTERS

Moleculin Biotech Partners with CIC biomaGUNE to Study Annamycin for Brain Tumors

Moleculin Announces New Annamycin Collaboration in Brain Tumors

THOMSON REUTERS

Moleculin Biotech Inc - Enters Research Agreement With Cic Biomagune

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MBRX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"MBRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MBRX\",,,,,undefined,":{"symbol":"MBRX","market":"US","secType":"STK","nameCN":"Moleculin Biotech","latestPrice":4.22,"timestamp":1770929509596,"preClose":4.18,"halted":0,"volume":18768,"delay":0,"changeRate":0.00956937799043063,"floatShares":3034900,"shares":3079200,"eps":-78.860825,"marketStatus":"Trading","change":0.04,"latestTime":"02-12 15:54:30 EST","open":4.22,"high":4.2601,"low":4.07,"amount":78686.303904,"amplitude":0.045478,"askPrice":4.22,"askSize":168,"bidPrice":4.18,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-78.860825,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770930000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":4.18,"preHourTrading":{"tag":"盘前","latestPrice":4.28,"preClose":4.18,"latestTime":"08:56 EST","volume":409,"amount":1764.5902544,"timestamp":1770904607996,"change":0.1,"changeRate":0.023923,"amplitude":0.016746},"postHourTrading":{"tag":"盘后","latestPrice":4.18,"preClose":4.18,"latestTime":"19:23 EST","volume":833,"amount":3483.49,"timestamp":1770855803320,"change":0,"changeRate":0,"amplitude":0.002392},"volumeRatio":0.301145},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MBRX\",,,,,undefined,":{"symbol":"MBRX","floatShares":3034900,"roa":"-69.18%","roe":"-503.80%","lyrEps":-158.02365,"volumeRatio":0.301145,"shares":3079200,"dividePrice":0,"high":4.2601,"amplitude":0.045478,"preClose":4.18,"low":4.07,"week52Low":3.13,"pbRate":"-0.48","week52High":91.2475,"institutionHeld":0,"latestPrice":4.22,"committee":-0.253731,"eps":-78.860825,"divideRate":0,"volume":18768,"delay":0,"ttmEps":-78.860825,"open":4.22,"prevYearClose":3.31,"prevWeekClose":4.31,"prevMonthClose":4.29,"prevQuarterClose":3.31,"fiveDayClose":3.91,"twentyDayClose":4.14,"sixtyDayClose":10.845},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MBRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-12-01","symbol":"MBRX","defaultRemindTime":1764599400000,"type":"split","dateTimestamp":1764565200000,"forFactor":25,"toFactor":1,"ratio":25},{"market":"US","date":"2025-11-13","symbol":"MBRX","fiscalQuarterEnding":"2025/09","expectedEps":-0.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2025-08-12","symbol":"MBRX","fiscalQuarterEnding":"2025/06","expectedEps":-0.39,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.49},{"date":"2025-05-14","symbol":"MBRX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.71,"defaultRemindTime":1747209600000,"name":null,"time":"Pre-Market","dateTimestamp":1747195200000,"actualEps":-0.69},{"date":"2025-03-24","symbol":"MBRX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":-1.29,"defaultRemindTime":1742803200000,"name":null,"time":"Pre-Market","dateTimestamp":1742788800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MBRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MBRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1742878800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MBRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MBRX","date":"2026-02-11","current":-0.053512,"percent":0.904177,"low":-8.228358,"twenty":-3.220107,"median":-0.844272,"eighty":-0.376369,"high":-0.041817,"avg":-1.780449,"sd":1.882375,"marketCap":12748008},"quantilePoints":[{"date":"2021-02-12","current":-8.059492,"twenty":-7.236948,"median":-4.037888,"eighty":-2.900783,"marketCap":149205383},{"date":"2021-02-19","current":-7.568247,"twenty":-7.421831,"median":-4.051721,"eighty":-2.914212,"marketCap":140110959},{"date":"2021-02-26","current":-6.493648,"twenty":-7.421831,"median":-4.067696,"eighty":-2.934119,"marketCap":120216908},{"date":"2021-03-05","current":-5.940997,"twenty":-7.321958,"median":-4.075277,"eighty":-2.939251,"marketCap":109985682},{"date":"2021-03-12","current":-6.816028,"twenty":-7.267317,"median":-4.075277,"eighty":-2.940877,"marketCap":126185124},{"date":"2021-03-19","current":-6.340134,"twenty":-7.246835,"median":-4.100664,"eighty":-2.943519,"marketCap":117374901},{"date":"2021-03-26","current":-6.277277,"twenty":-7.195277,"median":-4.12239,"eighty":-2.948181,"marketCap":108942147},{"date":"2021-04-01","current":-6.654242,"twenty":-7.154554,"median":-4.134797,"eighty":-2.95472,"marketCap":115484365},{"date":"2021-04-09","current":-6.211718,"twenty":-7.101216,"median":-4.144871,"eighty":-2.95472,"marketCap":107804370},{"date":"2021-04-16","current":-5.638077,"twenty":-7.011134,"median":-4.180688,"eighty":-2.956046,"marketCap":97848822},{"date":"2021-04-23","current":-5.736415,"twenty":-6.994135,"median":-4.216616,"eighty":-2.961351,"marketCap":99555487},{"date":"2021-04-30","current":-5.752805,"twenty":-6.968887,"median":-4.283448,"eighty":-2.961632,"marketCap":99839931},{"date":"2021-05-07","current":-5.490569,"twenty":-6.958418,"median":-4.313035,"eighty":-2.964509,"marketCap":95288823},{"date":"2021-05-14","current":-4.558623,"twenty":-6.929504,"median":-4.313035,"eighty":-2.972969,"marketCap":93866602},{"date":"2021-05-21","current":-5.028299,"twenty":-6.917858,"median":-4.333189,"eighty":-2.979684,"marketCap":103537707},{"date":"2021-05-28","current":-5.111183,"twenty":-6.871273,"median":-4.393653,"eighty":-2.98345,"marketCap":105244372},{"date":"2021-06-04","current":-5.152625,"twenty":-6.871273,"median":-4.406671,"eighty":-2.98345,"marketCap":106097705},{"date":"2021-06-11","current":-5.332207,"twenty":-6.862082,"median":-4.441121,"eighty":-2.98345,"marketCap":109795480},{"date":"2021-06-18","current":-5.083555,"twenty":-6.853723,"median":-4.474466,"eighty":-2.999883,"marketCap":104675484},{"date":"2021-06-25","current":-5.415139,"twenty":-6.821696,"median":-4.484072,"eighty":-3.002764,"marketCap":111503126},{"date":"2021-07-02","current":-4.91783,"twenty":-6.821696,"median":-4.517181,"eighty":-3.002764,"marketCap":101263043},{"date":"2021-07-09","current":-4.91783,"twenty":-6.817162,"median":-4.520391,"eighty":-3.002764,"marketCap":101263043},{"date":"2021-07-16","current":-4.544849,"twenty":-6.814048,"median":-4.525978,"eighty":-3.004822,"marketCap":93582980},{"date":"2021-07-23","current":-4.558663,"twenty":-6.813144,"median":-4.542261,"eighty":-3.005507,"marketCap":93867427},{"date":"2021-07-30","current":-4.310009,"twenty":-6.768027,"median":-4.525978,"eighty":-3.014121,"marketCap":88747386},{"date":"2021-08-06","current":-4.296194,"twenty":-6.755203,"median":-4.520391,"eighty":-3.025372,"marketCap":88462939},{"date":"2021-08-13","current":-5.759701,"twenty":-6.708226,"median":-4.520391,"eighty":-3.027649,"marketCap":84800072},{"date":"2021-08-20","current":-5.371842,"twenty":-6.69658,"median":-4.525978,"eighty":-3.027649,"marketCap":79089630},{"date":"2021-08-27","current":-5.779094,"twenty":-6.688933,"median":-4.543555,"eighty":-3.027649,"marketCap":85085594},{"date":"2021-09-03","current":-6.147559,"twenty":-6.679696,"median":-4.546236,"eighty":-3.027649,"marketCap":90510515},{"date":"2021-09-10","current":-5.934237,"twenty":-6.668654,"median":-4.558623,"eighty":-3.027649,"marketCap":87369771},{"date":"2021-09-17","current":-6.031202,"twenty":-6.657551,"median":-4.57079,"eighty":-3.027649,"marketCap":88797382},{"date":"2021-09-24","current":-5.740308,"twenty":-6.647625,"median":-4.571143,"eighty":-3.028316,"marketCap":84514550},{"date":"2021-10-01","current":-5.430021,"twenty":-6.640295,"median":-4.595196,"eighty":-3.035197,"marketCap":79946196},{"date":"2021-10-08","current":-5.255484,"twenty":-6.638349,"median":-4.600065,"eighty":-3.045512,"marketCap":77376497},{"date":"2021-10-15","current":-5.255484,"twenty":-6.638349,"median":-4.61476,"eighty":-3.049661,"marketCap":77376497},{"date":"2021-10-22","current":-5.333056,"twenty":-6.633061,"median":-4.625073,"eighty":-3.049749,"marketCap":78518585},{"date":"2021-10-29","current":-5.119734,"twenty":-6.629535,"median":-4.655883,"eighty":-3.049749,"marketCap":75377842},{"date":"2021-11-05","current":-5.003376,"twenty":-6.603268,"median":-4.664895,"eighty":-3.049749,"marketCap":73664709},{"date":"2021-11-12","current":-4.493596,"twenty":-6.573592,"median":-4.662654,"eighty":-3.050384,"marketCap":70585407},{"date":"2021-11-19","current":-4.002393,"twenty":-6.559225,"median":-4.651352,"eighty":-3.050808,"marketCap":62869593},{"date":"2021-11-26","current":-3.91143,"twenty":-6.546414,"median":-4.625073,"eighty":-3.054203,"marketCap":61440739},{"date":"2021-12-03","current":-3.583961,"twenty":-6.533455,"median":-4.615601,"eighty":-3.064281,"marketCap":56296863},{"date":"2021-12-10","current":-4.238898,"twenty":-6.528828,"median":-4.603452,"eighty":-3.071796,"marketCap":66584615},{"date":"2021-12-17","current":-3.893237,"twenty":-6.521887,"median":-4.595196,"eighty":-3.071849,"marketCap":61154968},{"date":"2021-12-23","current":-3.693117,"twenty":-6.521887,"median":-4.590744,"eighty":-3.071849,"marketCap":58011488},{"date":"2021-12-31","current":-3.383842,"twenty":-6.521887,"median":-4.57079,"eighty":-3.071849,"marketCap":53153383},{"date":"2022-01-07","current":-3.311071,"twenty":-6.521887,"median":-4.564726,"eighty":-3.071849,"marketCap":52010300},{"date":"2022-01-14","current":-3.110951,"twenty":-6.517795,"median":-4.554887,"eighty":-3.071849,"marketCap":48866820},{"date":"2022-01-21","current":-2.783483,"twenty":-6.501428,"median":-4.544849,"eighty":-3.071849,"marketCap":43722944},{"date":"2022-01-28","current":-2.56517,"twenty":-6.493648,"median":-4.53412,"eighty":-3.056373,"marketCap":40293694},{"date":"2022-02-04","current":-2.710712,"twenty":-6.493648,"median":-4.525978,"eighty":-3.049749,"marketCap":42579861},{"date":"2022-02-11","current":-2.692519,"twenty":-6.478297,"median":-4.518786,"eighty":-3.049528,"marketCap":42294090},{"date":"2022-02-18","current":-2.474207,"twenty":-6.469401,"median":-4.493679,"eighty":-3.027649,"marketCap":38864839},{"date":"2022-02-25","current":-2.56517,"twenty":-6.464804,"median":-4.493596,"eighty":-3.027649,"marketCap":40293694},{"date":"2022-03-04","current":-2.401436,"twenty":-6.463655,"median":-4.474466,"eighty":-3.005507,"marketCap":37721756},{"date":"2022-03-11","current":-2.383243,"twenty":-6.463655,"median":-4.4674,"eighty":-3.002188,"marketCap":37435985},{"date":"2022-03-18","current":-2.692519,"twenty":-6.445671,"median":-4.424589,"eighty":-2.98345,"marketCap":42294090},{"date":"2022-03-25","current":-3.182563,"twenty":-6.438135,"median":-4.406707,"eighty":-2.977299,"marketCap":50583658},{"date":"2022-04-01","current":-3.272466,"twenty":-6.437375,"median":-4.399361,"eighty":-2.982508,"marketCap":52012575},{"date":"2022-04-08","current":-3.326408,"twenty":-6.405363,"median":-4.352398,"eighty":-2.982508,"marketCap":52869925},{"date":"2022-04-14","current":-3.596117,"twenty":-6.373321,"median":-4.313035,"eighty":-2.982508,"marketCap":57156676},{"date":"2022-04-22","current":-3.272466,"twenty":-6.347193,"median":-4.303161,"eighty":-2.982508,"marketCap":52012575},{"date":"2022-04-29","current":-2.858913,"twenty":-6.326447,"median":-4.268566,"eighty":-2.962474,"marketCap":45439557},{"date":"2022-05-06","current":-2.643146,"twenty":-6.277248,"median":-4.216616,"eighty":-2.953539,"marketCap":42010156},{"date":"2022-05-13","current":-1.934764,"twenty":-6.230731,"median":-4.173408,"eighty":-2.937568,"marketCap":35437139},{"date":"2022-05-20","current":-2.043985,"twenty":-6.230731,"median":-4.135144,"eighty":-2.89691,"marketCap":37437622},{"date":"2022-05-27","current":-2.356043,"twenty":-6.230731,"median":-4.100664,"eighty":-2.893757,"marketCap":43153290},{"date":"2022-06-03","current":-2.387249,"twenty":-6.216696,"median":-4.075277,"eighty":-2.876893,"marketCap":43724857},{"date":"2022-06-10","current":-2.34044,"twenty":-6.180904,"median":-4.058788,"eighty":-2.869844,"marketCap":42867507},{"date":"2022-06-17","current":-2.324837,"twenty":-6.133327,"median":-4.028164,"eighty":-2.855029,"marketCap":42581723},{"date":"2022-06-24","current":-2.278029,"twenty":-6.07916,"median":-4.012846,"eighty":-2.850547,"marketCap":41724373},{"date":"2022-07-01","current":-2.293632,"twenty":-6.019566,"median":-4.004608,"eighty":-2.849536,"marketCap":42010156},{"date":"2022-07-08","current":-2.636896,"twenty":-5.963394,"median":-4.004608,"eighty":-2.830815,"marketCap":48297391},{"date":"2022-07-15","current":-2.580258,"twenty":-5.940997,"median":-3.994243,"eighty":-2.819408,"marketCap":47259997},{"date":"2022-07-22","current":-2.948955,"twenty":-5.928624,"median":-3.973281,"eighty":-2.818063,"marketCap":54013058},{"date":"2022-07-29","current":-2.636896,"twenty":-5.876058,"median":-3.954705,"eighty":-2.806653,"marketCap":48297391},{"date":"2022-08-05","current":-2.652499,"twenty":-5.815779,"median":-3.940978,"eighty":-2.784554,"marketCap":48583174},{"date":"2022-08-12","current":-2.222786,"twenty":-5.766607,"median":-3.93784,"eighty":-2.76529,"marketCap":46342863},{"date":"2022-08-19","current":-2.305111,"twenty":-5.752805,"median":-3.91143,"eighty":-2.755163,"marketCap":48059266},{"date":"2022-08-26","current":-2.016972,"twenty":-5.720382,"median":-3.908675,"eighty":-2.745889,"marketCap":42051857},{"date":"2022-09-02","current":-1.962089,"twenty":-5.670493,"median":-3.900336,"eighty":-2.722463,"marketCap":40907589},{"date":"2022-09-09","current":-1.97581,"twenty":-5.640183,"median":-3.893237,"eighty":-2.714667,"marketCap":41193656},{"date":"2022-09-16","current":-1.797438,"twenty":-5.596232,"median":-3.876372,"eighty":-2.703491,"marketCap":37474784},{"date":"2022-09-23","current":-1.577904,"twenty":-5.526985,"median":-3.862833,"eighty":-2.695817,"marketCap":32897711},{"date":"2022-09-30","current":-1.454415,"twenty":-5.440626,"median":-3.841713,"eighty":-2.690922,"marketCap":30323108},{"date":"2022-10-07","current":-1.481857,"twenty":-5.411208,"median":-3.82533,"eighty":-2.674744,"marketCap":30895242},{"date":"2022-10-14","current":-1.37209,"twenty":-5.371842,"median":-3.811766,"eighty":-2.668102,"marketCap":28606706},{"date":"2022-10-21","current":-1.286334,"twenty":-5.344063,"median":-3.787827,"eighty":-2.661258,"marketCap":26818786},{"date":"2022-10-28","current":-1.357958,"twenty":-5.332588,"median":-3.784081,"eighty":-2.655824,"marketCap":28312056},{"date":"2022-11-04","current":-1.272339,"twenty":-5.288972,"median":-3.765888,"eighty":-2.64511,"marketCap":26526998},{"date":"2022-11-11","current":-1.073658,"twenty":-5.255484,"median":-3.750324,"eighty":-2.637068,"marketCap":26927334},{"date":"2022-11-18","current":-1.198533,"twenty":-5.23884,"median":-3.74716,"eighty":-2.636896,"marketCap":30059218},{"date":"2022-11-25","current":-1.472484,"twenty":-5.218697,"median":-3.714856,"eighty":-2.626865,"marketCap":36929896},{"date":"2022-12-02","current":-1.539373,"twenty":-5.197645,"median":-3.714856,"eighty":-2.621231,"marketCap":38607487},{"date":"2022-12-09","current":-1.518142,"twenty":-5.180271,"median":-3.693117,"eighty":-2.606679,"marketCap":38075009},{"date":"2022-12-16","current":-1.483899,"twenty":-5.158922,"median":-3.655815,"eighty":-2.601296,"marketCap":37216175},{"date":"2022-12-23","current":-1.381167,"twenty":-5.152911,"median":-3.65025,"eighty":-2.594501,"marketCap":34639670},{"date":"2022-12-30","current":-1.209948,"twenty":-5.124997,"median":-3.617947,"eighty":-2.587166,"marketCap":30345496},{"date":"2023-01-06","current":-1.381167,"twenty":-5.124997,"median":-3.585684,"eighty":-2.576597,"marketCap":34639670},{"date":"2023-01-13","current":-1.483899,"twenty":-5.124997,"median":-3.564996,"eighty":-2.56247,"marketCap":37216175},{"date":"2023-01-20","current":-1.461069,"twenty":-5.124997,"median":-3.553341,"eighty":-2.547444,"marketCap":36643618},{"date":"2023-01-27","current":-1.449655,"twenty":-5.121576,"median":-3.536555,"eighty":-2.539774,"marketCap":36357340},{"date":"2023-02-03","current":-1.403996,"twenty":-5.119734,"median":-3.521038,"eighty":-2.528785,"marketCap":35212227},{"date":"2023-02-10","current":-1.337563,"twenty":-5.119734,"median":-3.488735,"eighty":-2.510592,"marketCap":33546087},{"date":"2023-02-17","current":-1.472484,"twenty":-5.114394,"median":-3.483457,"eighty":-2.499636,"marketCap":36929896},{"date":"2023-02-24","current":-1.43824,"twenty":-5.090269,"median":-3.464544,"eighty":-2.493412,"marketCap":36071062},{"date":"2023-03-03","current":-1.381167,"twenty":-5.063718,"median":-3.450298,"eighty":-2.474314,"marketCap":34639670},{"date":"2023-03-10","current":-1.187119,"twenty":-5.04989,"median":-3.434291,"eighty":-2.461859,"marketCap":29772940},{"date":"2023-03-17","current":-1.118631,"twenty":-5.018906,"median":-3.424129,"eighty":-2.456738,"marketCap":28055270},{"date":"2023-03-24","current":-0.996179,"twenty":-5.001753,"median":-3.403043,"eighty":-2.435919,"marketCap":28914105},{"date":"2023-03-31","current":-0.946863,"twenty":-4.988177,"median":-3.395078,"eighty":-2.423552,"marketCap":27482713},{"date":"2023-04-06","current":-0.918154,"twenty":-4.988177,"median":-3.382543,"eighty":-2.408128,"marketCap":26649416},{"date":"2023-04-14","current":-0.946228,"twenty":-4.984446,"median":-3.365649,"eighty":-2.400207,"marketCap":27464280},{"date":"2023-04-20","current":-0.813785,"twenty":-4.984446,"median":-3.362043,"eighty":-2.387249,"marketCap":23620108},{"date":"2023-04-28","current":-0.699041,"twenty":-4.985249,"median":-3.342966,"eighty":-2.356895,"marketCap":20289672},{"date":"2023-05-05","current":-0.79344,"twenty":-4.985249,"median":-3.341543,"eighty":-2.34044,"marketCap":23029605},{"date":"2023-05-12","current":-0.7383,"twenty":-4.986857,"median":-3.328604,"eighty":-2.337487,"marketCap":22202901},{"date":"2023-05-19","current":-0.62569,"twenty":-4.98962,"median":-3.317536,"eighty":-2.324837,"marketCap":18816368},{"date":"2023-05-26","current":-0.615851,"twenty":-4.98962,"median":-3.311071,"eighty":-2.310472,"marketCap":18520485},{"date":"2023-06-02","current":-0.564538,"twenty":-4.98962,"median":-3.294916,"eighty":-2.306159,"marketCap":16977359},{"date":"2023-06-09","current":-0.610621,"twenty":-4.98962,"median":-3.278548,"eighty":-2.29487,"marketCap":18363205},{"date":"2023-06-16","current":-0.582202,"twenty":-4.992383,"median":-3.270745,"eighty":-2.291297,"marketCap":17508550},{"date":"2023-06-23","current":-0.591872,"twenty":-4.995145,"median":-3.259541,"eighty":-2.269684,"marketCap":17799370},{"date":"2023-06-30","current":-0.548552,"twenty":-4.997908,"median":-3.245815,"eighty":-2.262426,"marketCap":16496616},{"date":"2023-07-07","current":-0.564242,"twenty":-4.997908,"median":-3.2383,"eighty":-2.247347,"marketCap":16968456},{"date":"2023-07-14","current":-0.709201,"twenty":-4.997908,"median":-3.227787,"eighty":-2.217051,"marketCap":21327789},{"date":"2023-07-20","current":-0.654434,"twenty":-4.997908,"median":-3.216919,"eighty":-2.20387,"marketCap":19680798},{"date":"2023-07-28","current":-0.641409,"twenty":-5.000671,"median":-3.194941,"eighty":-2.168808,"marketCap":19289081},{"date":"2023-08-04","current":-0.611805,"twenty":-5.001212,"median":-3.177182,"eighty":-2.144839,"marketCap":18398816},{"date":"2023-08-11","current":-0.621673,"twenty":-5.001212,"median":-3.160125,"eighty":-2.07519,"marketCap":18695571},{"date":"2023-08-18","current":-0.586595,"twenty":-5.001212,"median":-3.142523,"eighty":-2.030693,"marketCap":17170815},{"date":"2023-08-25","current":-0.570403,"twenty":-5.001212,"median":-3.122596,"eighty":-2.016133,"marketCap":16696829},{"date":"2023-09-01","current":-0.570301,"twenty":-5.001212,"median":-3.104845,"eighty":-1.965194,"marketCap":16693848},{"date":"2023-09-08","current":-0.397683,"twenty":-5.001212,"median":-3.07346,"eighty":-1.948368,"marketCap":11640977},{"date":"2023-09-15","current":-0.399211,"twenty":-5.001212,"median":-3.065528,"eighty":-1.901704,"marketCap":11685693},{"date":"2023-09-22","current":-0.427726,"twenty":-5.001753,"median":-3.050808,"eighty":-1.79195,"marketCap":12520386},{"date":"2023-09-29","current":-0.430781,"twenty":-5.001753,"median":-3.049749,"eighty":-1.685173,"marketCap":12609817},{"date":"2023-10-06","current":-0.499013,"twenty":-5.001753,"median":-3.027649,"eighty":-1.609459,"marketCap":14607117},{"date":"2023-10-13","current":-0.412959,"twenty":-5.001753,"median":-3.027649,"eighty":-1.577904,"marketCap":12088134},{"date":"2023-10-20","current":-0.626313,"twenty":-5.001753,"median":-3.027649,"eighty":-1.540332,"marketCap":18333422},{"date":"2023-10-27","current":-0.496976,"twenty":-5.003376,"median":-3.028205,"eighty":-1.52385,"marketCap":14547496},{"date":"2023-11-03","current":-0.519585,"twenty":-5.003376,"median":-3.028205,"eighty":-1.506728,"marketCap":15209288},{"date":"2023-11-10","current":-0.547896,"twenty":-5.003376,"median":-3.028205,"eighty":-1.483899,"marketCap":16038018},{"date":"2023-11-17","current":-0.693345,"twenty":-5.003376,"median":-3.027649,"eighty":-1.472484,"marketCap":18214180},{"date":"2023-11-24","current":-0.636607,"twenty":-5.003376,"median":-3.027649,"eighty":-1.472484,"marketCap":16723658},{"date":"2023-12-01","current":-0.679388,"twenty":-5.003376,"median":-3.010907,"eighty":-1.454415,"marketCap":17847512},{"date":"2023-12-07","current":-0.6475,"twenty":-5.003376,"median":-3.010907,"eighty":-1.449655,"marketCap":17009838},{"date":"2023-12-15","current":-0.681998,"twenty":-5.005598,"median":-3.005336,"eighty":-1.43824,"marketCap":17916076},{"date":"2023-12-22","current":-0.76007,"twenty":-5.005598,"median":-3.005336,"eighty":-1.426825,"marketCap":19967034},{"date":"2023-12-29","current":-0.851078,"twenty":-5.00782,"median":-3.005443,"eighty":-1.418232,"marketCap":22357832},{"date":"2024-01-05","current":-1.157425,"twenty":-5.010041,"median":-3.00555,"eighty":-1.415411,"marketCap":30405553},{"date":"2024-01-12","current":-0.903555,"twenty":-5.010041,"median":-3.002764,"eighty":-1.401318,"marketCap":23736379},{"date":"2024-01-19","current":-0.701832,"twenty":-5.012263,"median":-2.975134,"eighty":-1.387165,"marketCap":18437125},{"date":"2024-01-26","current":-0.620049,"twenty":-5.010041,"median":-2.962755,"eighty":-1.381167,"marketCap":16288689},{"date":"2024-02-02","current":-0.65757,"twenty":-5.010041,"median":-2.948955,"eighty":-1.37209,"marketCap":17274363},{"date":"2024-02-09","current":-0.627044,"twenty":-5.010041,"median":-2.933352,"eighty":-1.369752,"marketCap":16472459},{"date":"2024-02-16","current":-0.635948,"twenty":-5.010041,"median":-2.903222,"eighty":-1.350843,"marketCap":16706348},{"date":"2024-02-23","current":-0.655026,"twenty":-5.010041,"median":-2.889463,"eighty":-1.324094,"marketCap":17207538},{"date":"2024-03-01","current":-0.800022,"twenty":-5.00782,"median":-2.876227,"eighty":-1.288444,"marketCap":21016585},{"date":"2024-03-08","current":-0.85217,"twenty":-5.00782,"median":-2.858329,"eighty":-1.269059,"marketCap":22386506},{"date":"2024-03-15","current":-0.681227,"twenty":-5.00782,"median":-2.850497,"eighty":-1.216797,"marketCap":17895839},{"date":"2024-03-22","current":-0.562177,"twenty":-5.00782,"median":-2.826724,"eighty":-1.187119,"marketCap":14768402},{"date":"2024-03-28","current":-0.41454,"twenty":-5.00782,"median":-2.819292,"eighty":-1.12548,"marketCap":12340438},{"date":"2024-04-05","current":-0.396581,"twenty":-5.010041,"median":-2.819868,"eighty":-1.084319,"marketCap":11805834},{"date":"2024-04-12","current":-0.356923,"twenty":-5.010041,"median":-2.817081,"eighty":-1.056695,"marketCap":10625251},{"date":"2024-04-19","current":-0.338479,"twenty":-5.010041,"median":-2.808468,"eighty":-0.951218,"marketCap":10076168},{"date":"2024-04-26","current":-0.322368,"twenty":-4.984446,"median":-2.774878,"eighty":-0.942537,"marketCap":9596584},{"date":"2024-05-03","current":-0.385357,"twenty":-4.974094,"median":-2.761076,"eighty":-0.928972,"marketCap":11471707},{"date":"2024-05-10","current":-0.357672,"twenty":-4.974094,"median":-2.747097,"eighty":-0.915662,"marketCap":10647526},{"date":"2024-05-17","current":-0.417701,"twenty":-4.974094,"median":-2.722422,"eighty":-0.898085,"marketCap":11204405},{"date":"2024-05-24","current":-0.427666,"twenty":-4.974094,"median":-2.703367,"eighty":-0.855223,"marketCap":11471707},{"date":"2024-05-31","current":-0.385314,"twenty":-4.974094,"median":-2.697971,"eighty":-0.828803,"marketCap":10335674},{"date":"2024-06-07","current":-0.384337,"twenty":-4.974094,"median":-2.690867,"eighty":-0.797102,"marketCap":10309450},{"date":"2024-06-14","current":-0.374858,"twenty":-4.974094,"median":-2.675203,"eighty":-0.790674,"marketCap":10055181},{"date":"2024-06-21","current":-0.325738,"twenty":-4.974094,"median":-2.668102,"eighty":-0.778182,"marketCap":8737606},{"date":"2024-06-28","current":-0.303333,"twenty":-4.974094,"median":-2.658563,"eighty":-0.774095,"marketCap":8136606},{"date":"2024-07-05","current":-0.312812,"twenty":-4.974094,"median":-2.656134,"eighty":-0.7557,"marketCap":8390875},{"date":"2024-07-12","current":-0.340388,"twenty":-4.974094,"median":-2.64511,"eighty":-0.713305,"marketCap":9130567},{"date":"2024-07-15","current":-0.374858,"twenty":-4.974094,"median":-2.64511,"eighty":-0.711355,"marketCap":10055181},{"date":"2024-08-02","current":-0.195615,"twenty":-4.986857,"median":-2.636896,"eighty":-0.701832,"marketCap":5247186},{"date":"2024-08-09","current":-0.189152,"twenty":-4.986857,"median":-2.625739,"eighty":-0.692211,"marketCap":5073821},{"date":"2024-08-16","current":-0.204821,"twenty":-4.986857,"median":-2.619908,"eighty":-0.672465,"marketCap":5154725},{"date":"2024-08-23","current":-0.510683,"twenty":-4.974094,"median":-2.60347,"eighty":-0.661386,"marketCap":12852365},{"date":"2024-08-30","current":-0.536006,"twenty":-4.974094,"median":-2.594501,"eighty":-0.65757,"marketCap":13489673},{"date":"2024-09-06","current":-0.525455,"twenty":-4.959273,"median":-2.58903,"eighty":-0.654434,"marketCap":13224128},{"date":"2024-09-13","current":-0.512793,"twenty":-4.925805,"median":-2.574402,"eighty":-0.651592,"marketCap":12905474},{"date":"2024-09-20","current":-0.278044,"twenty":-4.917787,"median":-2.562149,"eighty":-0.646935,"marketCap":6997536},{"date":"2024-09-27","current":-0.275784,"twenty":-4.862574,"median":-2.543279,"eighty":-0.644469,"marketCap":6940645},{"date":"2024-10-04","current":-0.278044,"twenty":-4.839659,"median":-2.530279,"eighty":-0.638873,"marketCap":6997536},{"date":"2024-10-11","current":-0.274653,"twenty":-4.839659,"median":-2.512967,"eighty":-0.635948,"marketCap":6912200},{"date":"2024-10-18","current":-0.266741,"twenty":-4.839659,"median":-2.497974,"eighty":-0.628952,"marketCap":6713083},{"date":"2024-10-25","current":-0.287086,"twenty":-4.837049,"median":-2.474207,"eighty":-0.62569,"marketCap":7225098},{"date":"2024-10-31","current":-0.287086,"twenty":-4.752061,"median":-2.460772,"eighty":-0.624124,"marketCap":7225098},{"date":"2024-11-08","current":-0.264481,"twenty":-4.713381,"median":-2.437821,"eighty":-0.621124,"marketCap":6656193},{"date":"2024-11-15","current":-0.291529,"twenty":-4.667079,"median":-2.424759,"eighty":-0.616561,"marketCap":8789588},{"date":"2024-11-22","current":-0.28177,"twenty":-4.667079,"median":-2.401436,"eighty":-0.611805,"marketCap":8495362},{"date":"2024-11-29","current":-0.275796,"twenty":-4.667079,"median":-2.387249,"eighty":-0.604465,"marketCap":8315249},{"date":"2024-12-06","current":-0.248913,"twenty":-4.667079,"median":-2.356043,"eighty":-0.59825,"marketCap":7504737},{"date":"2024-12-13","current":-0.244931,"twenty":-4.667079,"median":-2.338254,"eighty":-0.593495,"marketCap":7384661},{"date":"2024-12-20","current":-0.180213,"twenty":-4.667079,"median":-2.324837,"eighty":-0.589406,"marketCap":5433429},{"date":"2024-12-27","current":-0.176231,"twenty":-4.667079,"median":-2.310472,"eighty":-0.582084,"marketCap":5313354},{"date":"2025-01-03","current":-0.176231,"twenty":-4.667079,"median":-2.306223,"eighty":-0.575062,"marketCap":5313354},{"date":"2025-01-10","current":-0.177226,"twenty":-4.669263,"median":-2.294406,"eighty":-0.570362,"marketCap":5343373},{"date":"2025-01-17","current":-0.173244,"twenty":-4.669263,"median":-2.283926,"eighty":-0.566314,"marketCap":5223297},{"date":"2025-01-24","current":-0.175235,"twenty":-4.669263,"median":-2.265174,"eighty":-0.56442,"marketCap":5283335},{"date":"2025-01-31","current":-0.153331,"twenty":-4.669263,"median":-2.248133,"eighty":-0.562387,"marketCap":4622918},{"date":"2025-02-07","current":-0.083675,"twenty":-4.669263,"median":-2.219202,"eighty":-0.56007,"marketCap":2522792},{"date":"2025-02-14","current":-0.126448,"twenty":-4.669263,"median":-2.168808,"eighty":-0.542573,"marketCap":3812406},{"date":"2025-02-21","current":-0.139391,"twenty":-4.669263,"median":-2.136557,"eighty":-0.53664,"marketCap":4202653},{"date":"2025-02-28","current":-0.126448,"twenty":-4.669263,"median":-2.07519,"eighty":-0.529915,"marketCap":3812406},{"date":"2025-03-07","current":-0.109522,"twenty":-4.671446,"median":-2.030693,"eighty":-0.519911,"marketCap":3302084},{"date":"2025-03-14","current":-0.115496,"twenty":-4.671446,"median":-2.016972,"eighty":-0.508863,"marketCap":3482198},{"date":"2025-03-21","current":-0.108526,"twenty":-4.671446,"median":-2.016972,"eighty":-0.50182,"marketCap":3272065},{"date":"2025-03-28","current":-0.675482,"twenty":-4.671446,"median":-1.96597,"eighty":-0.498418,"marketCap":14700518},{"date":"2025-04-04","current":-0.558849,"twenty":-4.671446,"median":-1.948368,"eighty":-0.498418,"marketCap":12162229},{"date":"2025-04-11","current":-0.470329,"twenty":-4.638525,"median":-1.875116,"eighty":-0.493187,"marketCap":10235761},{"date":"2025-04-17","current":-0.591208,"twenty":-4.595196,"median":-1.701084,"eighty":-0.493187,"marketCap":12866453},{"date":"2025-04-25","current":-0.714081,"twenty":-4.566151,"median":-1.609459,"eighty":-0.49288,"marketCap":15540548},{"date":"2025-05-02","current":-0.649749,"twenty":-4.553113,"median":-1.577904,"eighty":-0.49288,"marketCap":14140498},{"date":"2025-05-09","current":-0.649749,"twenty":-4.553113,"median":-1.539373,"eighty":-0.49288,"marketCap":14140498},{"date":"2025-05-16","current":-0.549617,"twenty":-4.475418,"median":-1.506728,"eighty":-0.49288,"marketCap":12767050},{"date":"2025-05-23","current":-0.566372,"twenty":-4.368028,"median":-1.483899,"eighty":-0.49288,"marketCap":13156264},{"date":"2025-05-30","current":-0.547146,"twenty":-4.296194,"median":-1.483784,"eighty":-0.49288,"marketCap":12709648},{"date":"2025-06-06","current":-0.419707,"twenty":-4.228663,"median":-1.472484,"eighty":-0.489644,"marketCap":9749383},{"date":"2025-06-13","current":-0.406571,"twenty":-4.002393,"median":-1.461069,"eighty":-0.464266,"marketCap":9444229},{"date":"2025-06-20","current":-0.354571,"twenty":-3.940538,"median":-1.449655,"eighty":-0.442788,"marketCap":8236329},{"date":"2025-06-27","current":-0.195835,"twenty":-3.816828,"median":-1.43824,"eighty":-0.430985,"marketCap":4549053},{"date":"2025-07-03","current":-0.352742,"twenty":-3.765888,"median":-1.426825,"eighty":-0.427024,"marketCap":8193836},{"date":"2025-07-11","current":-0.554012,"twenty":-3.725864,"median":-1.415411,"eighty":-0.422336,"marketCap":12869143},{"date":"2025-07-18","current":-1.086632,"twenty":-3.615274,"median":-1.409703,"eighty":-0.422336,"marketCap":25241381},{"date":"2025-07-25","current":-0.828369,"twenty":-3.530431,"median":-1.392582,"eighty":-0.422336,"marketCap":19242173},{"date":"2025-08-01","current":-0.816665,"twenty":-3.455744,"median":-1.381167,"eighty":-0.422336,"marketCap":18970306},{"date":"2025-08-08","current":-0.880906,"twenty":-3.401293,"median":-1.37209,"eighty":-0.422336,"marketCap":20462556},{"date":"2025-08-15","current":-0.73896,"twenty":-3.383274,"median":-1.369752,"eighty":-0.422336,"marketCap":19619379},{"date":"2025-08-22","current":-0.680669,"twenty":-3.383274,"median":-1.35734,"eighty":-0.422336,"marketCap":18071756},{"date":"2025-08-29","current":-0.448418,"twenty":-3.383274,"median":-1.324094,"eighty":-0.422336,"marketCap":11905492},{"date":"2025-09-05","current":-0.432334,"twenty":-3.383842,"median":-1.28985,"eighty":-0.421853,"marketCap":11478457},{"date":"2025-09-12","current":-0.520301,"twenty":-3.383274,"median":-1.271378,"eighty":-0.422336,"marketCap":13813999},{"date":"2025-09-19","current":-0.570117,"twenty":-3.383274,"median":-1.224623,"eighty":-0.422336,"marketCap":15136616},{"date":"2025-09-26","current":-0.819756,"twenty":-3.383274,"median":-1.190488,"eighty":-0.422336,"marketCap":21764523},{"date":"2025-10-03","current":-0.932177,"twenty":-3.383274,"median":-1.124338,"eighty":-0.422336,"marketCap":24749288},{"date":"2025-10-10","current":-0.962193,"twenty":-3.383274,"median":-1.08551,"eighty":-0.422336,"marketCap":25546215},{"date":"2025-10-17","current":-0.899364,"twenty":-3.383274,"median":-1.070018,"eighty":-0.422336,"marketCap":23878113},{"date":"2025-10-24","current":-0.914279,"twenty":-3.383274,"median":-1.021953,"eighty":-0.422336,"marketCap":24274101},{"date":"2025-10-31","current":-0.842315,"twenty":-3.383274,"median":-0.97515,"eighty":-0.422336,"marketCap":22363456},{"date":"2025-11-07","current":-0.851077,"twenty":-3.383274,"median":-0.95082,"eighty":-0.422336,"marketCap":22596099},{"date":"2025-11-14","current":-0.84623,"twenty":-3.383274,"median":-0.946546,"eighty":-0.422336,"marketCap":22467403},{"date":"2025-11-21","current":-0.417396,"twenty":-3.383274,"median":-0.935191,"eighty":-0.420044,"marketCap":21458765},{"date":"2025-11-28","current":-0.270045,"twenty":-3.383274,"median":-0.928079,"eighty":-0.418029,"marketCap":13883286},{"date":"2025-12-05","current":-0.305397,"twenty":-3.380203,"median":-0.924038,"eighty":-0.414937,"marketCap":15700790},{"date":"2025-12-12","current":-0.198053,"twenty":-3.380203,"median":-0.91642,"eighty":-0.409901,"marketCap":10182095},{"date":"2025-12-19","current":-0.229509,"twenty":-3.380203,"median":-0.912974,"eighty":-0.40792,"marketCap":11799264},{"date":"2025-12-26","current":-0.233703,"twenty":-3.380203,"median":-0.905143,"eighty":-0.406728,"marketCap":12014917},{"date":"2026-01-02","current":-0.198348,"twenty":-3.380203,"median":-0.900389,"eighty":-0.403557,"marketCap":10197275},{"date":"2026-01-09","current":-0.246166,"twenty":-3.380203,"median":-0.893492,"eighty":-0.397276,"marketCap":12655631},{"date":"2026-01-16","current":-0.255749,"twenty":-3.358773,"median":-0.88622,"eighty":-0.39284,"marketCap":13148307},{"date":"2026-01-23","current":-0.285696,"twenty":-3.329922,"median":-0.873415,"eighty":-0.38937,"marketCap":14687922},{"date":"2026-01-30","current":-0.256348,"twenty":-3.272466,"median":-0.859078,"eighty":-0.385323,"marketCap":13179100},{"date":"2026-02-06","current":-0.234187,"twenty":-3.237941,"median":-0.851624,"eighty":-0.378965,"marketCap":12039785},{"date":"2026-02-11","current":-0.247963,"twenty":-3.220107,"median":-0.844272,"eighty":-0.376369,"marketCap":12748008}],"updateTime":1770929670420},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MBRX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609006433","title":"Moleculin Biotech Inc. Held Special Stockholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2609006433","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609006433?lang=en_us&edition=fundamental","pubTime":"2026-02-06 00:55","pubTimestamp":1770310542,"startTime":"0","endTime":"0","summary":"Moleculin Biotech Inc. held a Special Meeting of Stockholders on February 5, 2026. Stockholders approved the issuance of up to 2,610,823 shares of common stock upon the exercise of certain warrants issued on December 11, 2025. A proposal to amend the company’s name from Moleculin Biotech, Inc. to Moleculin Inc. was not approved. Stockholders approved an adjournment of the meeting, if necessary, to solicit additional proxies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 05, 2026, and is solely responsible for","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL7qSXB3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2609306717","title":"Moleculin Biotech nimmt an virtueller Corporate-Connect-Konferenz von Webull Financial teil","url":"https://stock-news.laohu8.com/highlight/detail?id=2609306717","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609306717?lang=en_us&edition=fundamental","pubTime":"2026-02-05 22:15","pubTimestamp":1770300910,"startTime":"0","endTime":"0","summary":"Moleculin Biotech Inc. wird am Mittwoch, den 11. Februar 2026, um 13:20 Uhr EST an der virtuellen Corporate Connect Webinar Series von Webull Financial teilnehmen. CEO Walter Klemp wird das Unternehmen prsentieren.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via GlobeNewswire  on February 05, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL3C6dPK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","BK4112","LU2210150020.SGD","LU0314104364.USD","BK4585","BK4588","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2095319765.USD","IE00BKPKM429.USD","SG9999014013.SGD","IE00B64PRP62.GBP","BK4139","SG9999014039.USD","SG9999014005.SGD","LU2210149790.SGD","SG9999014021.USD","BK4127"],"gpt_icon":0},{"id":"2603768709","title":"BUZZ-Moleculin Biotech rises as cancer drug shows no heart damage in trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2603768709","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603768709?lang=en_us&edition=fundamental","pubTime":"2026-01-13 22:09","pubTimestamp":1768313362,"startTime":"0","endTime":"0","summary":"BUZZ-Moleculin Biotech rises as cancer drug shows no heart damage in trials** Shares of drug developer Moleculin Biotech MBRX.O rise 2.2% to $4.14 premarket ** Co says its experimental cancer drug, annamycin, showed no signs of causing heart damage in patients in five clinical trials** Independent expert reviewed data from 90 patients with leukemia and sarcoma; found no heart issues - MBRX** Annamycin, also called naxtarubicin, tested for leukemia and sarcoma spread** Leukemia is a blood cancer; sarcoma is a cancer that starts in soft tissues and can spread to lungs** Drug being studied alone and with chemotherapy; late-stage leukemia trial ongoing - MBRX** Co says it is working to secure funding and will monitor patients long-term for heart issues** As of last close, stock down ~92% over the past year","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nL4N3YE1BP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2603068731","title":"Moleculin Biotech Reports Annamycin Shows No Cardiotoxicity in 90 Clinical Trial Subjects","url":"https://stock-news.laohu8.com/highlight/detail?id=2603068731","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603068731?lang=en_us&edition=fundamental","pubTime":"2026-01-13 21:55","pubTimestamp":1768312515,"startTime":"0","endTime":"0","summary":"Moleculin Biotech Inc. announced that an independent assessment has confirmed the absence of cardiotoxicity in 90 subjects treated with Annamycin, a next-generation anthracycline, across five clinical trials. The reviewed data included subjects with acute myeloid leukemia  and soft tissue sarcoma  treated with Annamycin as monotherapy and in combination with cytarabine at multiple sites in the United States and European Union. The assessment, conducted by an expert affiliated with a leading cancer research institute, found no evidence of cardiotoxicity based on serial ECGs, echocardiography, and cardiac biomarker analysis. Most subjects received doses above the FDA-recommended lifetime maximum for other anthracyclines. These results have already been assessed and reported by the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL2hYY4d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","BK4112","LU2210150020.SGD","LU0314104364.USD","BK4585","IE00B3QW5Z07.USD","BK4588","IE00BGHQF748.EUR","LU2095319765.USD","NDAQ","IE00BKPKM429.USD","SG9999014013.SGD","IE00B64PRP62.GBP","BK4139","SG9999014039.USD","SG9999014005.SGD","LU2210149790.SGD","SG9999014021.USD"],"gpt_icon":0},{"id":"2602480665","title":"BRIEF-Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding On Track, Global Trial Expansion, And Multiple Externally/Iit Funded Clinical Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2602480665","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602480665?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:41","pubTimestamp":1768225306,"startTime":"0","endTime":"0","summary":"BRIEF-Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding On Track, Global Trial Expansion, And Multiple Externally/Iit Funded Clinical ProgramsJan 12 (Reuters) - Moleculin Bio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA31DX7F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2602467548","title":"Moleculin Biotech Inc - First Miracle Trial Unblinding Expected Q1 2026; Global Trial NOW Spans Nine Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2602467548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602467548?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:36","pubTimestamp":1768224960,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA31DX7F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2602414548","title":"Moleculin Biotech Inc - Primary Efficacy Data for Miracle Expected in 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2602414548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602414548?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:36","pubTimestamp":1768224960,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA31DX7F:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2601218809","title":"BRIEF-Moleculin Biotech Regains Nasdaq Listing Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2601218809","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601218809?lang=en_us&edition=fundamental","pubTime":"2026-01-07 22:24","pubTimestamp":1767795878,"startTime":"0","endTime":"0","summary":"BRIEF-Moleculin Biotech Regains Nasdaq Listing Compliance Jan 7 (Reuters) - Moleculin Biotech Inc MBRX.O:MOLECULIN BIOTECH INC - REGAINS NASDAQ LISTING COMPLIANCE - SEC FILINGSource text: [ID:n0001437749-26-000695]Further company coverage: MBRX.O ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nFWN3Y802A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2601480525","title":"Moleculin Biotech Inc - Regains Nasdaq Listing Compliance - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2601480525","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601480525?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:33","pubTimestamp":1767792787,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nFWN3Y802A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2592190604","title":"Moleculin Biotech Inc. Announces Date for Upcoming Special Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2592190604","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592190604?lang=en_us&edition=fundamental","pubTime":"2025-12-20 05:37","pubTimestamp":1766180224,"startTime":"0","endTime":"0","summary":"Moleculin Biotech Inc. has announced a Special Meeting of Stockholders to be held on February 5, 2026. Among the proposals to be voted on are the Nasdaq Proposal, a Name Change Proposal, and an Adjournment Proposal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL68MPly:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2592918178","title":"Moleculin Reports Positive Phase 1 Results for WP1066 in Pediatric Brain Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2592918178","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592918178?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:31","pubTimestamp":1765978266,"startTime":"0","endTime":"0","summary":"Moleculin Biotech Inc. has announced positive results from a Phase 1 clinical trial evaluating WP1066 for the treatment of pediatric recurrent malignant brain tumors. The trial, conducted at the Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta and led by Dr. Tobey MacDonald, demonstrated that WP1066 induces anti-tumor immune responses. The results, which found WP1066 to be safe and effective, were recently published in the Journal of Clinical Investigation Insight and support the advancement to a Phase 2 trial.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL2L4hf3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2592918925","title":"Moleculin Biotech Inc - WP1066 Found Safe and Effective, Warranting Phase 2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2592918925","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592918925?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:31","pubTimestamp":1765978260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUA6QLSKT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2592918904","title":"Moleculin Announces Positive Results From Phase 1 Clinical Trial Evaluating WP1066 for the Treatment of Pediatric Recurrent Malignant Brain Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2592918904","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592918904?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:31","pubTimestamp":1765978260,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUA6QLSKT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2590151885","title":"Moleculin Biotech Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2590151885","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590151885?lang=en_us&edition=fundamental","pubTime":"2025-12-11 19:44","pubTimestamp":1765453440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MBRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 11, 2025 06:44 ET (11:44 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX"],"gpt_icon":0},{"id":"2590059587","title":"Moleculin Biotech Raises $6.8 Million Through Warrant Exercises","url":"https://stock-news.laohu8.com/highlight/detail?id=2590059587","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590059587?lang=en_us&edition=fundamental","pubTime":"2025-12-10 21:30","pubTimestamp":1765373420,"startTime":"0","endTime":"0","summary":"Moleculin Biotech Inc. has announced agreements with certain holders for the immediate exercise of outstanding warrants, resulting in gross proceeds of approximately $6.5 million before fees. The exercised warrants cover 727,969 shares originally issued in February 2025 at $6.63 per share and 316,360 shares issued in August 2025 at $6.3219 per share. In connection with this transaction, Moleculin will issue new unregistered warrants to purchase up to 2,610,823 shares of common stock at an exercise price of $6.63 per share, exercisable upon shareholder approval for five years. The company intends to use the proceeds for working capital and general corporate purposes. Roth Capital Partners and Maxim Group LLC served as financial advisors for the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDL1ngN56:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","MBRX","IE00BKPKM429.USD","SG9999014005.SGD","LU2095319765.USD","IE00B64PRP62.GBP","BK4139","LU2210149790.SGD","NDAQ","BK4112","BK4585","SG9999014039.USD","LU2210150020.SGD","SG9999014021.USD","SG9999014013.SGD","LU0314104364.USD"],"gpt_icon":0},{"id":"2590496523","title":"Moleculin Biotech Nears First Unblinding in Pivotal Phase 3 AML Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2590496523","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590496523?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:07","pubTimestamp":1765285638,"startTime":"0","endTime":"0","summary":"Moleculin Biotech Inc. has announced the completion of treatment for the first 45 patients in its pivotal Phase 2B/3 \"MIRACLE\" clinical trial, evaluating Annamycin in combination with cytarabine for adult patients with relapsed or refractory acute myeloid leukemia . As of early December 2025, 78% of the target subjects for the first interim unblinding have consented across seven countries, and recruitment continues. The company expects to complete treatment of the first cohort and conduct the first planned unblinding of data in the first quarter of 2026. Results from this interim analysis have not yet been presented. The trial will continue enrolling the remaining subjects to reach a total of 90 for Part A, with a second unblinding planned to inform dose selection for Part B.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informationa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL46x5BS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4139","IE00BKPKM429.USD","SG9999014005.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2095319765.USD","LU2210150020.SGD","NDAQ","SG9999014039.USD","MBRX","BK4585","SG9999014021.USD","LU2210149790.SGD","BK4112","SG9999014013.SGD","BK4588"],"gpt_icon":0},{"id":"2590349523","title":"Moleculin Announces Completion of Treatment for the 45 Patients in Pivotal “Miracle” Phase 3 Aml Trial on Pace for Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2590349523","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590349523?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:07","pubTimestamp":1765285620,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nTUA7XF4LK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2589353040","title":"Moleculin Biotech Partners with CIC biomaGUNE to Study Annamycin for Brain Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2589353040","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589353040?lang=en_us&edition=fundamental","pubTime":"2025-12-08 21:21","pubTimestamp":1765200072,"startTime":"0","endTime":"0","summary":"Moleculin Biotech Inc. has announced a new collaboration with CIC biomaGUNE, a non-profit research organization in Spain, to conduct preclinical studies on Annamycin for the treatment of glioblastoma multiforme, a form of brain cancer. Under the agreement, Moleculin will provide Annamycin while CIC biomaGUNE, led by Principal Investigator Jesús Ruiz-Cabello, will evaluate the effects of intra-arterial delivery of both liposomal and free Annamycin compared to other treatments in mouse models. This partnership aims to explore new therapeutic options for hard-to-treat brain tumors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL5Pb3px:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2589530493","title":"Moleculin Announces New Annamycin Collaboration in Brain Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2589530493","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589530493?lang=en_us&edition=fundamental","pubTime":"2025-12-08 21:21","pubTimestamp":1765200060,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nTUA3LBV0D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2589353045","title":"Moleculin Biotech Inc - Enters Research Agreement With Cic Biomagune","url":"https://stock-news.laohu8.com/highlight/detail?id=2589353045","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589353045?lang=en_us&edition=fundamental","pubTime":"2025-12-08 21:21","pubTimestamp":1765200060,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nTUA3LBV0D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBRX","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":69,"code":"91000000","status":"200"}]}}